<DOC>
	<DOCNO>NCT01035801</DOCNO>
	<brief_summary>The purpose study see whether IN-105 ( oral insulin ) able control increase blood glucose eating meal . This study also tell whether single tablet IN-105 safe patient Type 1 diabetes mellitus currently take insulin injection .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Oral Insulin ( IN-105 ) Type 1 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>1 . Male female patient age 1845 year inclusive 2 . Established diagnosis T1DM least 1year 3 . Body mass index 18.529.9 kg/m2 inclusive 4 . Stable weight 5 kg gain loss within 3 month screen 5 . HbA1c ≤ 8.0 % 6 . On stable insulin insulin analogue regimen least 3 month 1 . Any hypersensitivity allergy 2 . Positive urine ketone test screen visit . 3 . ECG abnormality 4. total daily insulin &gt; 1 IU/kg and/or &gt; 0.7 IU/Kg basal insulin and/or &gt; 0.6 IU/Kg prandial insulin . 5 . Patient clinically significant abnormality 6 . Evidence severe secondary complication diabetes 7 . History drug alcohol dependence abuse 8 . Patients currently systemic inhaled glucocorticoid drug , may affect glycemic control . 9 . Patients treat bloodglucose lower drug insulin insulin analogue last 4 week prior screen study 10 . History two severe episode hypoglycemia ( define ADA criterion ) within 6 month prior screen and/or patient history low blood glucose level episode suggestive hypoglycemia unawareness ( loss warning symptom hypoglycemia ) . Investigator assess criterion base subject fill questionnaire . 11 . Any hospitalization emergency room visit due poor diabetes control within 6 month prior screen . 12 . Impaired hepatic function ( ALT AST value great 2 X Upper limit reference range and/or serum bilirubin ≥1.5 X Upper limit reference range screen visit ) . 13 . Impaired renal function ( serum creatinine ≥1.5 X Upper limit reference range screen ) . 14 . Hemoglobinopathies , haemolytic anaemia , anaemia chronic disease , factor affect measurement HbA1c . 15 . Any electively plan surgery require hospitalization study period . 16 . Pregnancy , lactation , plan pregnancy study duration . 17 . The patient receive another investigational drug within 6 week prior screen 18 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>